Skip to main content
. 2021 Jul 29;9(8):833. doi: 10.3390/vaccines9080833

Table 3.

The neutralizing ability of recombinant scFv against the G2b PEDV.

Time Post-Challenge (hr) Concentration of scFv (µg/mL) Protection
24 6.25 No CPE
12.5 No CPE
25 No CPE
48 6.25 Few CPE
12.5 No CPE
25 No CPE
72 6.25 CPE
12.5 Few CPE
25 No CPE